Page last updated: 2024-10-24

carbamazepine and Nasopharyngeal Carcinoma

carbamazepine has been researched along with Nasopharyngeal Carcinoma in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CY1
Xiao, F1
Liu, JL1

Other Studies

1 other study available for carbamazepine and Nasopharyngeal Carcinoma

ArticleYear
Superficial siderosis of the central nervous system with seizures onset.
    Singapore medical journal, 2015, Volume: 56, Issue:10

    Topics: Ataxia; Carbamazepine; Carcinoma; Central Nervous System; Diagnosis, Differential; Female; Gait; Hum

2015